Small molecule inhibitors 10,058-F4 and MYCi975 have demonstrated efficacy in disrupting MYC – MAX dimerization, resulting in suppressed growth of T-ALL cell lines.101 However, while these approaches show potential, relatively few compounds have been investigated in the context of LSCs in T-ALL, highlighting the need for further exploration in this area. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.